TY - JOUR
T1 - Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury
AU - Imai, Naohiko
AU - Hishikawa, Keiichi
AU - Marumo, Takeshi
AU - Hirahashi, Junichi
AU - Inowa, Toshihiko
AU - Matsuzaki, Yumi
AU - Okano, Hideyuki
AU - Kitamura, Tadaichi
AU - Salant, David
AU - Fujitaa, Toshiro
PY - 2007/10
Y1 - 2007/10
N2 - Bone morphogenic protein (BMP)-7 is expressed in the adult kidney and reverses chronic renal injury when given exogenously. Here, we report that a histone deacetylase inhibitor, trichostatin A (TSA), attenuates chronic renal injury, in part, by augmenting the expression of BMP-7 in kidney side population (SP) cells. We induced accelerated nephrotoxic serum nephritis (NTN) in C57BL/6 mice and treated them with TSA for 3 weeks. Compared with vehicle-treated NTN mice, treatment with TSA prevented the progression of proteinuria, glomerulosclerosis, interstitial fibrosis, and loss of kidney SP cells. Basal gene expression of renoprotective factors such as BMP-7, vascular endothelial growth factor, and hepatocyte growth factor was significantly higher in kidney SP cells as compared with non-SP cells. Treatment with TSA significantly upregulated the expression of BMP-7 in SP cells but not in non-SP cells. Moreover, initiation of treatment with TSA after 3 weeks of NTN (for 3 weeks, until 6 weeks) partially but significantly reversed renal dysfunction. Our results indicate an important role of SP cells in the kidney as one of the possible generator cells of BMP-7 and TSA as a stimulator of the cells in reversing chronic renal disease.
AB - Bone morphogenic protein (BMP)-7 is expressed in the adult kidney and reverses chronic renal injury when given exogenously. Here, we report that a histone deacetylase inhibitor, trichostatin A (TSA), attenuates chronic renal injury, in part, by augmenting the expression of BMP-7 in kidney side population (SP) cells. We induced accelerated nephrotoxic serum nephritis (NTN) in C57BL/6 mice and treated them with TSA for 3 weeks. Compared with vehicle-treated NTN mice, treatment with TSA prevented the progression of proteinuria, glomerulosclerosis, interstitial fibrosis, and loss of kidney SP cells. Basal gene expression of renoprotective factors such as BMP-7, vascular endothelial growth factor, and hepatocyte growth factor was significantly higher in kidney SP cells as compared with non-SP cells. Treatment with TSA significantly upregulated the expression of BMP-7 in SP cells but not in non-SP cells. Moreover, initiation of treatment with TSA after 3 weeks of NTN (for 3 weeks, until 6 weeks) partially but significantly reversed renal dysfunction. Our results indicate an important role of SP cells in the kidney as one of the possible generator cells of BMP-7 and TSA as a stimulator of the cells in reversing chronic renal disease.
KW - Anti-glomerular basement membrane disease
KW - Chronic renal failure
KW - Side population
KW - Stem cell
KW - Transcription regulation
UR - http://www.scopus.com/inward/record.url?scp=35348912462&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35348912462&partnerID=8YFLogxK
U2 - 10.1634/stemcells.2007-0049
DO - 10.1634/stemcells.2007-0049
M3 - Article
C2 - 17641247
AN - SCOPUS:35348912462
SN - 1066-5099
VL - 25
SP - 2469
EP - 2475
JO - International Journal of Cell Cloning
JF - International Journal of Cell Cloning
IS - 10
ER -